Bio-Key International Common Stock

The latest common stock for BKYI is $110 as of June 2026. That compares with $690 in the prior-year period — down 84.1% year over year. Investors often review this figure alongside Bio-Key International's historical trend and sector peers before judging valuation or financial health.

Over the past year, BKYI's common stock moved from $690 to $110 — a 84.1% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Bio-Key International's operating scale or balance-sheet position.

A common stock figure of $110 for BKYI is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting BKYI's common stock ($110), review year-over-year change from $690, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Bio-Key International's common stock against similar Technology names. You can also browse sector and industry screens on Stockcircle for a broader set of Technology companies and their key multiples and fundamentals.